Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10734018 | 0.72 | — | — | |
| SCHEMBL455522 | 0.72 | TRPA1 (0.36) | TSHRTRPA1 | |
| SCHEMBL7920635 | 0.69 | TSHR (0.39) | TSHRTRPA1 | |
| SCHEMBL71390 | 0.69 | — | — | |
| SCHEMBL12616208 | 0.67 | — | — | |
| SCHEMBL11272579 | 0.67 | TRPA1 (0.36) | TRPA1 | |
| Water SCHEMBL20545911 | 0.67 | — | — | |
| SCHEMBL5860713 | 0.67 | — | — | |
| SCHEMBL10899343 | 0.65 | CASP1 (0.30) | — | |
| SCHEMBL2169853 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024099398-A1 | CLASS OF SULFONAMIDE COMPOUNDS CONTAINING ORTHO-FUSED HETEROCYCLE AND USE THEREOF | 南京明德新药研发有限公司 | 2024-05-16 | — | — | WO | disclosed |
| CN-109206481-A | Peptide compound, application thereof and composition containing peptide compound | 凯惠科技发展(上海)有限公司 | 2019-01-15 | — | — | CN | disclosed |
| US-6515124-B2 | (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis | HOFFMAN-LA ROCHE INC. | 2003-02-04 | — | — | US | disclosed |
| US-20020161237-A1 | Dehydroamino acids | HOFFMANN-LA ROCHE INC. | 2002-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020161237-A1 | Dehydroamino acids | HSD3B1, CYP8B1, TH | TSHR 1248/4885TRPA1 4068/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.